These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 26164382)
21. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysis. Liu J; Wei Y; Wang T; Zhang Z; Huang H; Wang C; Li H; Jia Q; Wu H; Zou T Int J Biol Markers; 2020 Dec; 35(4):3-11. PubMed ID: 33208027 [TBL] [Abstract][Full Text] [Related]
22. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy]. Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of pretreatment albumin to bilirubin ratio in patients with hepatocellular cancer: A meta-analysis. Xu YX; Wang YB; Tan YL; Xi C; Xu XZ Medicine (Baltimore); 2019 Jan; 98(2):e14027. PubMed ID: 30633195 [TBL] [Abstract][Full Text] [Related]
24. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis. Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914 [TBL] [Abstract][Full Text] [Related]
25. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis. Ma W; Zhang P; Qi J; Gu L; Zang M; Yao H; Shi X; Wang C; Jiang Y Sci Rep; 2016 Oct; 6():35378. PubMed ID: 27739490 [TBL] [Abstract][Full Text] [Related]
26. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis. Zhang Y; Yang X Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601 [TBL] [Abstract][Full Text] [Related]
27. Prognostic effect of albumin-to-alkaline phosphatase ratio on patients with hepatocellular carcinoma: a systematic review and meta-analysis. Zhang X; Xin Y; Chen Y; Zhou X Sci Rep; 2023 Jan; 13(1):1808. PubMed ID: 36720974 [TBL] [Abstract][Full Text] [Related]
28. Prognostic value of SPARC in hepatocellular carcinoma: A systematic review and meta-analysis. Yang X; Xia Y; Wang S; Sun C PLoS One; 2022; 17(8):e0273317. PubMed ID: 35981080 [TBL] [Abstract][Full Text] [Related]
29. The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies. Wang Z; Wang J; Wang P PLoS One; 2018; 13(10):e0202987. PubMed ID: 30312295 [TBL] [Abstract][Full Text] [Related]
30. The prognostic value of vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Wang M; Cao L; Wang Y; Huang H; Tian X; Lei J Clin Transl Oncol; 2024 Aug; 26(8):2037-2046. PubMed ID: 38523240 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A meta-analysis. Ding W; Xu X; Qian Y; Xue W; Wang Y; Du J; Jin L; Tan Y Medicine (Baltimore); 2018 Dec; 97(50):e13301. PubMed ID: 30557978 [TBL] [Abstract][Full Text] [Related]
32. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis. Luo Y; Ren F; Liu Y; Shi Z; Tan Z; Xiong H; Dang Y; Chen G Int J Clin Exp Med; 2015; 8(7):10235-47. PubMed ID: 26379815 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis. Zhang CH; Xu GL; Jia WD; Ge YS; Li JS; Ma JL; Ren WH Int J Cancer; 2012 Jun; 130(11):2685-92. PubMed ID: 21780114 [TBL] [Abstract][Full Text] [Related]
34. Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma. Hao Q; Han Y; Xia W; Wang Q; Qian H Can J Gastroenterol Hepatol; 2019; 2019():1684039. PubMed ID: 31187026 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of LncRNA-HOTAIR for patients with hepatocellular carcinoma: a meta-analysis. Xu CL; Liu YH Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8444-8450. PubMed ID: 36459027 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of microvessel density in hepatocellular carcinoma patients: a meta-analysis. Li Y; Ma X; Zhang J; Liu X; Liu L Int J Biol Markers; 2014 Sep; 29(3):e279-87. PubMed ID: 24803279 [TBL] [Abstract][Full Text] [Related]
37. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients. Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma. Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028 [TBL] [Abstract][Full Text] [Related]
39. Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis. Sun P; Li Y; Chang L; Tian X Medicine (Baltimore); 2019 May; 98(19):e15603. PubMed ID: 31083251 [TBL] [Abstract][Full Text] [Related]
40. The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma. Ren N; Qin LX; Tu H; Liu YK; Zhang BH; Tang ZY J Cancer Res Clin Oncol; 2006 Jun; 132(6):399-407. PubMed ID: 16502316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]